These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
21 related articles for article (PubMed ID: 38365538)
1. Corrigendum to "Methionine enkephalin inhibited cervical cancer migration as well as invasion and activated CD11b+ NCR1+ NKs of tumor microenvironment" [Int. Immunopharmacol. 124(Pt B) (2023) 110967. doi: 10.1016/j.intimp.2023.110967. Epub 2023 Sep 21.]. Qu N; Meng Y; Zhai J; Griffin N; Shan Y; Gao Y; Shan F Int Immunopharmacol; 2024 Sep; 139():112734. PubMed ID: 39069388 [No Abstract] [Full Text] [Related]
2. Corrigendum to "(E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol alleviates inflammatory responses in LPS-induced mice liver sepsis through inhibition of STAT3 phosphorylation" [Int. Immunopharmacol. 125(Part B) (2023) 111124]. Kim B; Yu JE; Yeo IJ; Son DJ; Lee HP; Roh YS; Lim KH; Yun J; Park H; Han SB; Hong JT Int Immunopharmacol; 2024 Aug; 137():112543. PubMed ID: 38926074 [No Abstract] [Full Text] [Related]
3. Corrigendum to "GTS-21 attenuates ACE/ACE2 ratio and glycocalyx shedding in lipopolysaccharide-induced acute lung injury by targeting macrophage polarization derived ADAM-17" [Int. Immunopharmacol. 129 (2024) 111603]. Zhu W; Wang F; Hu C; Zhao Q; Zhang D; Wang X; Hu B; Li J Int Immunopharmacol; 2024 May; 132():111914. PubMed ID: 38582738 [No Abstract] [Full Text] [Related]
4. Corrigendum to "The effectiveness of blood routine parameters and some biomarkers as a potential diagnostic tool in the diagnosis and prognosis of Covid-19 disease" [Int. Immunopharmacol. 98 (2021) 107838]. Huyut MT; İlkbahar F Int Immunopharmacol; 2023 Oct; 123():110823. PubMed ID: 37661504 [No Abstract] [Full Text] [Related]
5. Redox-Regulated Iron Metabolism and Ferroptosis in Ovarian Cancer: Molecular Insights and Therapeutic Opportunities. Liu D; Hu Z; Lu J; Yi C Antioxidants (Basel); 2024 Jun; 13(7):. PubMed ID: 39061859 [TBL] [Abstract][Full Text] [Related]
6. Erastin enhances metastatic potential of ferroptosis-resistant ovarian cancer cells by M2 polarization through STAT3/IL-8 axis. Cang W; Wu A; Gu L; Wang W; Tian Q; Zheng Z; Qiu L Int Immunopharmacol; 2022 Dec; 113(Pt B):109422. PubMed ID: 36410184 [TBL] [Abstract][Full Text] [Related]
7. Iron Administration Overcomes Resistance to Erastin-Mediated Ferroptosis in Ovarian Cancer Cells. Battaglia AM; Sacco A; Perrotta ID; Faniello MC; Scalise M; Torella D; Levi S; Costanzo F; Biamonte F Front Oncol; 2022; 12():868351. PubMed ID: 35433479 [TBL] [Abstract][Full Text] [Related]
8. Erastin synergizes with cisplatin via ferroptosis to inhibit ovarian cancer growth in vitro and in vivo. Cheng Q; Bao L; Li M; Chang K; Yi X J Obstet Gynaecol Res; 2021 Jul; 47(7):2481-2491. PubMed ID: 33882617 [TBL] [Abstract][Full Text] [Related]
9. Corrigendum to "Salidroside postconditioning attenuates ferroptosis-mediated lung ischemia-reperfusion injury by activating the Nrf2/SLC7A11 signaling axis" [Int. Immunopharmacol. 115 (2023) 109731]. Wang Y; Chen Z; Luo J; Zhang J; Sang AM; Cheng ZS; Li XY Int Immunopharmacol; 2023 Apr; 117():110002. PubMed ID: 36925352 [No Abstract] [Full Text] [Related]
10. Corrigendum to "Liproxstatin-1 alleviates LPS/IL-13-induced bronchial epithelial cell injury and neutrophilic asthma in mice by inhibiting ferroptosis" [Int. Immunopharmacol. 109 (2022) 108770]. Bao C; Liu C; Liu Q; Hua L; Hu J; Li Z; Xu S Int Immunopharmacol; 2023 Feb; 115():109482. PubMed ID: 36610897 [No Abstract] [Full Text] [Related]
11. Corrigendum to "Erastin enhances metastatic potential of ferroptosis-resistant ovarian cancer cells by M2 polarization through STAT3/IL-8 axis". [Int. Immunopharmacol. 113(Pt B) (2022) 109422]. Cang W; Wu A; Gu L; Wang W; Tian Q; Zheng Z; Qiu L Int Immunopharmacol; 2024 Mar; 129():111651. PubMed ID: 38365538 [No Abstract] [Full Text] [Related]
12. The Role of Erastin in Ferroptosis and Its Prospects in Cancer Therapy. Zhao Y; Li Y; Zhang R; Wang F; Wang T; Jiao Y Onco Targets Ther; 2020; 13():5429-5441. PubMed ID: 32606760 [TBL] [Abstract][Full Text] [Related]